This week’s Current Climate newsletter also looks at who gets electricity when the grid is under strain and boom times for clean energy investment
In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and more
This week’s Current Climate newsletter also looks at Waymo’s reliance on imported Chinese EVs and a potential “super cycle” for cleantech investment.
In this week’s edition of InnovationRx, we look at Fortell’s efforts to make a better hearing aid, Abby Care’s business getting payment for caregivers, J&J’s $5.5 billion talc settlement, Scribe Therapeutics’ IPO, and more.
This week’s Current Climate newsletter also looks at why Tesla’s founders are backing an anti-Cybertruck and Sila’s expanding production of silicon battery anodes.
In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company, and more.
This week’s Current Climate newsletter also looks at how the U.S. EV market is about to get quirkier and the bipartisan appeal of recycling.
In this week’s edition of InnovationRx, Thyme Care gets new leadership, the intestinal illness spreads, Chai Discovery confirms its $400 million raise, and more.
This week’s Current Climate newsletter also looks at California’s new EV rebates and Peak Energy’s sodium-ion battery plans
Catapulting satellites into space. Making all the data center heat useful. Why memory technology needs disrupting.